Ketorolac Injection Administration Instructions
Ketorolac tromethamine injection should be administered intramuscularly by injecting slowly and deeply into the muscle, or intravenously over no less than 15 seconds, with a maximum treatment duration of 5 days. 1
Dosing Guidelines
Intramuscular (IM) Administration
Patients <65 years of age:
- Single-dose treatment: 60 mg
- Multiple-dose treatment: 30 mg every 6 hours (maximum daily dose: 120 mg)
Patients ≥65 years, renally impaired, or <50 kg (110 lbs):
- Single-dose treatment: 30 mg
- Multiple-dose treatment: 15 mg every 6 hours (maximum daily dose: 60 mg)
Intravenous (IV) Administration
Patients <65 years of age:
- Single-dose treatment: 30 mg
- Multiple-dose treatment: 30 mg every 6 hours (maximum daily dose: 120 mg)
Patients ≥65 years, renally impaired, or <50 kg (110 lbs):
- Single-dose treatment: 15 mg
- Multiple-dose treatment: 15 mg every 6 hours (maximum daily dose: 60 mg)
Clinical Effects Timeline
- Onset of action: ~30 minutes
- Peak analgesic effect: 1-2 hours after administration
- Duration of analgesic effect: 4-6 hours 1
Important Precautions
Contraindications
- Active peptic ulcer disease
- Recent gastrointestinal bleeding
- Advanced renal impairment or risk of renal failure
- History of hypersensitivity to aspirin or NSAIDs
- Cerebrovascular bleeding
- Hemorrhagic diathesis
- Incomplete hemostasis
- High risk of bleeding
- Pregnancy 2, 1
Renal Considerations
- Hypovolemia should be corrected prior to administration
- Monitor blood pressure, BUN, creatinine, and liver function tests at baseline and periodically
- Discontinue immediately if BUN or creatinine doubles or if hypertension develops/worsens 3, 1
Compatibility Information
Ketorolac should NOT be mixed in a small volume (e.g., in a syringe) with:
- Morphine sulfate
- Meperidine hydrochloride
- Promethazine hydrochloride
- Hydroxyzine hydrochloride
This will result in precipitation of ketorolac from solution 1.
Clinical Pearls
- Inspect solution visually for particulate matter and discoloration before administration
- For breakthrough pain, do not increase the dose or frequency of ketorolac
- Consider supplementing with low doses of opioids "prn" unless contraindicated
- Patients should be switched to alternative analgesics as soon as possible
- Ketorolac therapy should not exceed 5 days 1
Pediatric Considerations
For children, the recommended intravenous dosage is:
- Initial dose: 0.5 mg/kg
- Followed by either:
- Bolus injections of 1.0 mg/kg every 6 hours, or
- IV infusion of 0.17 mg/kg/h
- Maximum daily dose: 90 mg
- Maximum duration: 48 hours
- Not recommended for infants <1 year of age 4
Remember that despite common practice of using higher doses, research suggests that ketorolac exhibits an analgesic ceiling effect, with 10 mg possibly being the ceiling dose 5. However, the FDA-approved dosing as outlined above should be followed for safe administration.